Story D L, Meierhenry E F, Tyson C A, Milman H A
Toxicol Ind Health. 1986 Dec;2(4):351-62. doi: 10.1177/074823378600200402.
Nine chlorinated aliphatics (CAs)--1,1-dichloroethane, 1,2-dichloroethane, 1,1,1-trichloroethane, 1,1,2-trichloroethane, trichloroethylene, tetrachloroethylene, 1,1,1,2-tetrachloroethane, 1,1,2,2-tetrachloroethane, and hexachloroethane--were examined in a rat liver foci assay for evidence of initiating and promoting potential. Young adult male Osborne-Mendel rats (ten/group) were given partial hepatectomies, followed 24 hr later by a single i.p. dose of either diethylnitrosamine (30 mg/kg body weight) or CA, 1 wk later either a diet containing 0.05% (w/w) phenobarbital or daily oral gavage (5 X/wk) of CA in corn oil for 7 weeks, and sacrificed 1 wk later. Putative preneoplastic markers monitored were foci with increased gamma-glutamyltranspeptidase activity [GGT(+)]. CAs were without significant effect in the initiation protocol at the maximum tolerated dose. In the promotion protocol, 1,1-dichloroethane, 1,1,2-trichloroethane, tetrachloroethylene, 1,1,2,2-tetrachloroethane, and hexachloroethane induced significant increases in GGT(+) foci above control levels. Two variants of GGT(+) foci were distinguishable, one associated predominantly with phenobarbital promotion, resembling preneoplastic foci in other models, and the other associated with CA promotion, which was less intensely stained and exhibited branching, resembling foci undergoing redifferentiation. The marked differences in response may relate to differences in cytotoxic potential or mechanism of action of the two types of agents.
研究了9种氯代脂肪烃(CAs)——1,1 - 二氯乙烷、1,2 - 二氯乙烷、1,1,1 - 三氯乙烷、1,1,2 - 三氯乙烷、三氯乙烯、四氯乙烯、1,1,1,2 - 四氯乙烷、1,1,2,2 - 四氯乙烷和六氯乙烷——在大鼠肝灶试验中引发和促进肿瘤发生的可能性。选用成年雄性奥斯本 - 孟德尔大鼠(每组10只)进行部分肝切除术,24小时后腹腔注射一次二乙基亚硝胺(30毫克/千克体重)或CAs,1周后给予含0.05%(w/w)苯巴比妥的饲料,或每周5次经口灌胃给予玉米油中的CAs,持续7周,1周后处死大鼠。监测的假定癌前标志物是γ - 谷氨酰转肽酶活性增加的病灶[GGT(+)]。在最大耐受剂量下,CAs在启动方案中无显著影响。在促进方案中,1,1 - 二氯乙烷、1,1,2 - 三氯乙烷、四氯乙烯、1,1,2,2 - 四氯乙烷和六氯乙烷诱导GGT(+)病灶显著增加,高于对照水平。GGT(+)病灶可分为两种类型,一种主要与苯巴比妥促进作用相关,类似于其他模型中的癌前病灶,另一种与CAs促进作用相关,其染色较浅且呈现分支,类似于正在进行再分化的病灶。反应的显著差异可能与两类药物的细胞毒性潜力或作用机制差异有关。